Cardiovascular Risk Profile of Antirheumatic Agents in Patients with Osteoarthritis and Rheumatoid Arthritis

被引：0
|
作者：
Michael T. Nurmohamed
Vokko P. van Halm
Ben A. C. Dijkmans
机构：
[1] VU University Medical Centre,Department of Rheumatology
[2] Jan van Breemen Institute,undefined
[3] Slotervaart Hospital,undefined
来源：
Drugs | 2002年 / 62卷
关键词：
Rheumatoid Arthritis; Infliximab; Etanercept; Celecoxib; Naproxen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Several new drugs have become available for the treatment of patients with osteoarthritis and rheumatoid arthritis (RA). These agents include selective cyclooxygenase (COX)-2 inhibitors, leflunomide and anti-tumour necrosis factor (TNF)-α antagonists.
引用
收藏
页码：1599 / 1609
页数：10
相关论文
共 50 条
  • [1] Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis
    Nurmohamed, MT
    van Halm, VP
    Dijkmans, BAC
    DRUGS, 2002, 62 (11) : 1599 - 1609
  • [2] Comparison of the cardiovascular risk profile of rheumatoid arthritis versus hand osteoarthritis patients
    Mathieu, Sylvain
    Lambert, C.
    Fayet, Francoise
    Couderc, Marion
    Beauger, Marine
    Malochet, Sandrine
    Pickering, Marie-Eva
    Tournadre, Anne
    Soubrier, Martin
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (11) : 2065 - 2072
  • [3] Comparison of the cardiovascular risk profile of rheumatoid arthritis versus hand osteoarthritis patients
    Sylvain Mathieu
    C. Lambert
    Françoise Fayet
    Marion Couderc
    Marine Beauger
    Sandrine Malochet
    Marie-Eva Pickering
    Anne Tournadre
    Martin Soubrier
    Rheumatology International, 2023, 43 : 2065 - 2072
  • [4] IMPACT OF CONVENTIONAL ANTIRHEUMATIC TREATMENT ON CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Gerasimova, D.
    Gerasimova, E.
    Popkova, T.
    Melkumyan, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1155 - 1155
  • [5] IMPROVING THE CARDIOVASCULAR RISK PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Shivacheva, T.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S362 - S362
  • [6] Markers of cardiovascular risk in patients with rheumatoid arthritis (RA) and osteoarthritis (OA).
    Wasko, MC
    Genovese, M
    DeMuro-Mercon, C
    Cai, B
    Holmes, R
    Gottesdiener, K
    Santanello, N
    Cunningham, A
    Chakravarty, E
    Tanaka, W
    Snyder, K
    Cannuscio, CC
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S396 - S396
  • [7] Cardiovascular profile in rheumatoid arthritis patients
    Hernandez, R.
    Rodriguez, S.
    Uceda, J.
    Marenco, J. L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 : 67 - 67
  • [8] Will Antirheumatic Treatment Improve Cardiovascular Outcomes in Patients with Rheumatoid Arthritis?
    Pieringer, Herwig
    Pichler, Max
    Pohanka, Erich
    Hoppe, Uta C.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (04) : 486 - 495
  • [9] EFFECT OF BIOLOGIC AGENTS ON LIPIDS AND CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS PATIENTS
    Pappas, D. A.
    John, A.
    Kremer, J.
    Reed, G.
    Greenberg, J.
    Shewade, A.
    Solomon, D. H.
    Curtis, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 49 - 49
  • [10] Effect of Biologic Agents on Lipids and Cardiovascular Risk in Rheumatoid Arthritis Patients
    Pappas, Dimitrios
    Reed, George
    Kane, Kevin
    Curtis, Jeffrey
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 545 - 547
12345